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ABSTRACT 
The identification and validation of gene-gene interactions is a major challenge in 
human studies. Here, we explore an approach for studying epistasis in humans using a 
Drosophila melanogaster model of neonatal diabetes mellitus. Expression of mutant 
preproinsulin, hINSC96Y, in the eye imaginal disc mimics the human disease activating 
conserved cell stress response pathways leading to cell death and reduction in eye area. 
Dominant-acting variants in wild-derived inbred lines from the Drosophila Genetics 
Reference Panel produce a continuous, highly heritable, distribution of eye 
degeneration phenotypes. A genome-wide association study (GWAS) in 154 sequenced 
lines identified 29 candidate SNPs in 16 loci with P < 10-5 including one SNP in an intron 
of the gene sulfateless (sfl) which exceeded a conservative genome-wide significance 
threshold of P = 0.05 level (-log10 P > 7.62). RNAi knock-downs of sfl enhanced the eye 
degeneration phenotype in a mutant-hINS-dependent manner. sfl encodes a protein 
required for sulfation of the glycosaminoglycan, heparan sulfate. Two additional genes 
in the heparan sulfate (HS) biosynthetic pathway (tout velu, ttv and brother of tout velu, 
botv) also modified the eye phenotype, suggesting a link between HS-modified proteins 
and cellular responses to misfolded proteins. Finally, intronic variants marking the QTL 
were associated with decreased sfl expression, a result consistent with that predicted by 
RNAi studies. The ability to create a model of human genetic disease in the fly, map a 
QTL by GWAS to a specific gene (and noncoding variant), validate its contribution to 
disease with available genetic resources, and experimentally link the variant to a 
molecular mechanism, demonstrate the many advantages Drosophila holds in 
determining the genetic underpinnings of human disease. 	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INTRODUCTION 
Limitations imposed by human subject research can be overcome by investigating 
models of human disease in experimental organisms. Drosophila routinely provide 
genetic insights relevant to human biology and disease, owing to the deep conservation 
of fundamental cellular and developmental processes. Motivated by the success of this 
approach, we constructed a fly model of protein misfolding disease, by creating a 
transgene of a diabetes-causing, human mutant preproinsulin (hINSC96Y) that could be 
expressed in the eye imaginal discs and other developing tissues (Park et al., 2013). 
The misfolded proinsulin protein causes the loss of insulin-secreting pancreatic beta 
cells and diabetes in humans and mice (Støy et al., 2007). When misexpressed in the 
Drosophila eye imaginal disc, it disrupts eye development, resulting in a reduced eye 
area in adult flies (Park et al., 2013). 	  
 To investigate the effect of genetic variation in this model of a human disease, we 
crossed the transgenic line bearing the mutant preproinsulin and an eye-specific Gal4 
driver (GMR>>hINSC96Y) with 178 lines from the Drosophila Genetics Reference Panel 
(DGRP) (Mackay et al., 2012) . The resulting F1 offspring exhibited extensive and highly 
heritable variation in the extent of eye degeneration (Park et al., 2013). The nearly 
continuous distribution of eye degeneration phenotypes among the lines suggested a 
polygenic basis for this genetic background variation.	  
 Drosophila’s many favorable attributes for mapping quantitative trait loci (QTL) — a 
high density of common variants, relatively little population subdivision, a decay of 
linkage disequilibrium (LD) over a scale of only 100’s of bp, controlled crosses allowing 
repeat measurements, and excellent resources for confirmatory genetics — allowed us 
to identify a variant in the heparan sulfate biosynthesis pathway gene, sulfateless (sfl), 
and then validate the gene by genetic analysis. Moreover, studies of two other genes in 
the HS biosynthetic pathway, tout-velo (ttv) and brother of tout-velo (botv), showed a 
similar effect implicating the HS-modified proteins, or proteoglycans (HSPG), in the 
response to misfolded proteins. 	  	  
MATERIALS AND METHODS 
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Drosophila stocks and crosses 
The {GMR-Gal4, UAS-hINSC96Y} line was generated by crossing the GMR-Gal4 line 
(Stock #1104, Bloomington Stock Center) with the UAS-hINSC96Y line (Park et al., 2013), 
and obtaining the recombinant 2nd chromosome, which was balanced over CyO. DGRP 
lines were obtained from the Bloomington stock center. RNAi lines against sfl (GD5070), 
ttv (GD4871), botv (GD37186) were from the Vienna Drosophila RNAi center. Mutant 
lines for ttv (ttv681) and botv (botv510) were described previously (Ren et al., 2009). 	  
 
Eye area measurement  
All crosses were reared at 25°C. Total eye area was measured as described in (Park et 
al., 2013). At least 10 images (independent flies) passing the quality check were 
collected for each cross. Raw data is available on the authors' website 
(http://openwetware.org/wiki/Kreitman:Publications).	  
 
Principal Component Analysis  
The whole-genome SNP dataset for the 154 DGRP lines used for GWAS (see Table S1 
for the list of line numbers) was downloaded from the DGRP website 
(http://dgrp.gnets.ncsu.edu/). To detect population structures, 900K SNPs (after LD 
pruning using PLINK v1.07, with parameter --indep-pairwise 50 5 0.5) were used to 
identify the top 15 principal components (PCs) (SmartPCA software in EIGENSOFT 
v3.0, no outlier exclusion). We tested for the presence of population structure in the 
sample, a possible confounding source of association in GWAS, by measuring the 
correlation between the hINSC96Y phenotype (line mean) and projection length in the 
direction of the top five principle components in each DGRP line.	  
 
Genome wide association  
The mean eye area of 154 DGRP lines crossed to the hINSC96Y line was regressed on 
each SNP with a minor allele frequency MAF > 5% (PLINK 1.07, quantitative trait mode). 
2,106,077 autosomal and 324,253 SNPs on the X chromosome were tested. The F1 
males in this cross received their X chromosome from the transgene-containing strain. 
The identity by descent of this X chromosome allowed us to test whether the X-linked 
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SNPs in the DGRP sample conformed to a null distribution assuming no association. 
This was tested and confirmed in quantile-quantile (Q-Q) plot analysis. Because an 
estimate of the total number of independent SNPs genome-wide does not exist for the 
fly, we adopted two thresholds to identify candidate SNPs on the autosomes. The first is 
a Bonferroni corrected threshold at P = 0.05 level (-log10 P > 7.62). This is conservative 
because it assumes all tests are independent while the number of independent SNPs 
must be much smaller than the total number tested. The second is an arbitrary 
threshold of P < 10-5 (or 10-6) as suggested by Mackay et al. (Mackay et al., 2012). We 
estimated the false discovery rate (FDR) associated with a P < 10-5 threshold by using X 
chromosome SNPs as negative controls and assuming an equal FDR between X 
chromosome and autosomes. We also compared the number of QTLs passing this 
threshold with an empirical null distribution by randomizing the phenotype relative to the 
genotype 2,000 times and carrying out GWAS on each of the permuted datasets.	  	  
Conditional analysis using sfl intronic SNPs as covariates 
To identify possible secondary associations in sfl or elsewhere in the genome 
independent of the intronic QTL variants in sfl, we fit a linear model with the most 
significant one, a 18 bp /4 bp insertion/deletion polymorphism, as a covariate. This 
analysis was performed either within the sfl locus or genome-wide, and in each case the 
p-values were corrected for multiple testing using Bonferroni's method. 	  
 
Expression of sfl and CG32396  
Expression profiles in adult tissues were assessed using data from FlyAtlas (Chintapalli 
et al., 2007) and modENCODE (Roy et al., 2010). To assay expression in the eye 
imaginal discs, we isolated total RNA from 10 pairs of discs from 3rd instar larvae. 
Individual larva were sexed and dissected in 1X phosphate buffer saline (PBS); the eye 
portions of the eye-antennal disc were collected and the isolated discs immediately 
dissolved in 300 µl Trizol (Invitrogen). Total RNA was extracted according to the 
manufacturer's instructions. cDNA libraries were constructed using (dT)20 primers after 
DNase I treatment (Invitrogen). Real time quantitative PCR was performed with primer 
pairs targeting either sfl or CG32396, with expression of the gene rp49 as an 
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endogenous reference (SYBR-Green assay). Primers used for qRT-PCR are listed in 
Table S2.	  
 
RNAi and validation studies  
All RNAi lines were originally from the Vienna Drosophila RNAi Center as P-element 
insertion lines on a co-isogenic w1118 background. Each RNAi line was first tested to 
determine whether it alone had an effect on eye development by crossing it to GMR-
Gal4 and comparing the eye area of the F1 males (or females) to the control cross 
between w1118 and GMR-Gal4. In all crosses, GMR-Gal4 was used as the maternal 
parent. To test its effect on the hINSC96Y-induced eye degeneration phenotype, the 
RNAi line was crossed to the GMR>>hINSC96Y line (used as maternal parent), so that 
both hINSC96Y and the RNAi constructs are driven by GMR-Gal4. The resulting 
phenotype was compared to the cross between hINSC96Y females and w1118 males. At 
least 10 individual flies were measured per cross and a t-test was used to determine 
significance at 0.05 level with multiple testing correction. For mutant lines, GMR-Gal4 
was replaced with w1118 in the first test and used as a control. The same scheme was 
used for the second test. It is worth noting that because the mutants were tested in 
heterozygous states, only dominant interaction with hINSC96Y will be revealed.	  
 
sfl expression studies   
Six lines carrying the 18 bp indel allele and eight carrying the 4 bp allele were randomly 
chosen and paired to form 15 crosses (Figure S1A). Three sets of ten 3rd instar 
wandering larvae were collected from each cross and dissected in 1X PBS to isolate 
eye imaginal discs. RNA isolation and cDNA library preparation are the same as 
described above. Genomic DNA was extracted from adult flies from the same cross. 
Because the 18 bp/4 bp polymorphism is in the intron of sfl, a SNP in the cDNA was 
identified that could be used to distinguish the two alleles in each cross (Figure S1B). 
Four such SNPs were chosen and pyro-sequencing assays were designed (primers 
listed in Table S2). Pyro-sequencing was performed as previously described (Wittkopp, 
2011). Briefly, each of the three cDNA and one gDNA sample per cross was analyzed 
by pyrosequencing in four replicate PCR amplifications to determine relative expression. 
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The ratio in genomic DNA analysis was used to account for amplification bias. The 
resulting 12 ratios were first log2 transformed and analyzed using ANOVA according to 
the model yij =  α + Li + εij, where α is the estimate of the relative expression ratio, 
which is expected to be significantly different from zero when the two alleles are 
differentially expressed; Li is a random effect term for the biological replicates (i = 1,2,3). 
For 13 of the 15 crosses the p-value > 0.1; for these crosses the data were fit a with a 
reduced ANOVA model yi =  α + εi, from which the estimate and the 95% confidence 
interval for the ratio of expression (α) were calculated. In the two cases where the 
random effect term was nominally significant (P < 0.1), a linear mixed-effect model was 
fit using the lme package in R to obtain an estimate and 95% confidence interval for the 
same ratio. 	  
 
RESULTS 
Effect of natural variation on hINSC96Y-induced eye phenotype 
 We crossed the transgenic fly line (w; P{GMR-Gal4}, P{UAS-hINSC96Y }/CyO) as the 
maternal parent to 178 inbred lines from DGRP representing a spectrum of natural 
variation (excluding recessive lethal variants eliminated in the formation of the DGRP). 
Among several eye phenotypes observed — rough eye, reduced total area, distortion of 
the oval shape and black lesion spots — we chose total eye area as the phenotype to 
carry out a GWAS. We quantified eye area in ten male progeny from each hINSC96Y x 
DGRP cross. We observed a continuously varying distribution of this phenotype, 
ranging from 13% to 86% of wild type fly eye area (Figure 1). ANOVA indicated that 
nearly 60% of the variance is between genotypes, indicating a large genetic component. 
Males were chosen for measurement and analysis because they showed a more severe 
phenotype than females (Park et al., 2013). However, we also measured F1 females for 
a subset of 38 lines and found a strong correlation between the two sexes from the 
same cross (r=0.8, Figure S2). 
9 	  
	  
Figure 1  Distribution of eye area in hINSC96Y x DGRP crosses. Mean ± 1 s.d., sorted 
by the mean, is shown for crosses between the transgenic {GMR>>hINSC96Y} line to 178 
DGRP lines, and two randomly chosen DGRP inbred lines (red). Representative 
photographs of eyes from across the range of the distribution are shown. The rightmost 
image is of a non-transgenic wild type fly eye.	  	  
  The observed variation in eye degeneration is consistent with the hypothesis that it 
reflects differences in cellular response to the expression of hINSC96Y. The severity of 
the eye degeneration phenotype is not correlated with body size of the same individual, 
or the mean eye size of the same line; neither is it correlated with GAL4 protein levels in 
eye imaginal discs (Park et al., 2013). The GWAS described below showed no evidence 
for association between eye area and SNPs in or surrounding the glass (gl) locus, the 
trans-activator of GMR-Gal4, a result consistent with Gal4 protein measurements. 
Finally, when we expressed mutant hINS in the notum (rather than the eye) and 
measured the loss of macrochaetae in F1 crosses to 38 DGRP lines for which we also 
collected eye degeneration data, we observed no correlation between the two traits, 
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indicating that the degeneration phenotypes are not caused by line-specific differences 
in mutant insulin expression (Park et al., 2013).	  	  
Genome-wide association analysis 
We carried out GWAS on the F1 males from crosses of hINSC96Y and 154 DGRP lines. 
Population structure is a potential confounding factor in GWAS. Little population 
structure was found within the full set of DGRP lines (Mackay et al., 2012) and we 
observed no evidence for population structure in the 154 lines examined using a 
principal component analysis on 900K autosomal SNPs (obtained by pruning a total of 2 
million based on pairwise LD) (Figure S3). There was no significant correlation between 
the hINSC96Y phenotype (line mean) and projection length in the direction of the top five 
principle components in each DGRP line.  
 We used mean eye area as a quantitative trait to perform single marker regression 
for 2.1 million autosomal SNPs. We restricted the analysis to bi-allelic sites for which the 
minor allele was present in at least four lines (Mackay et al., 2012). Because of the 
direction of the cross, all F1 males inherited their X-chromosome from the 
GMR>>hINSC96Y tester line and we expected to observe no association between the 
phenotype and X-linked SNPs. Quantile-quantile (Q-Q) plots for autosomal and X-
chromosomal SNPs revealed that only the former and not the latter showed an excess 
of small p-values (Figure 2A,B). We observed association of a SNP (list SNP) on 
chromosome 3L with eye area (Figure 2C), with a p-value that approached genome-
wide significance (raw P = 2.4 x10-8, Bonferroni corrected P = 0.0502). 
 The Bonferroni correction is conservative because whereas it assumes complete 
independence of SNPs, LD is common between SNPs separated by short distances. To 
identify additional association beyond the peak on chromosome 3L, we used the 
threshold P < 10-5 suggested by (Mackay et al., 2012) for nominating candidate SNPs. 
Thirty SNPs, 29 of which were on autosomes and one on the X chromosome, were 
identified using this criteria (Table S3). The 29 autosomal SNPs were distributed in 16 
unlinked loci. Two methods were used to assess the false discovery rate (FDR) at this 
threshold. First, assuming that the FDR for autosomal and X-linked SNPs are the same, 
we expected 6.5 autosomal SNPs while observing 29, suggesting a FDR of 22%. 
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Second, we randomized the phenotype relative to the genotype 2,000 times and carried 
out GWAS on each of the permuted datasets. The resulting number of SNPs passing 
	  
Figure 2  Genome-wide scan identifies candidate locus associated with the 
hINSC96Y-induced phenotype. Quantile-Quantile (QQ) plot reveals an excess of small 
p-values on autosomes (A) but not on the X chromosome (B), which is not variable in 
the mapping population due to cross design. (C) Manhattan plot shows a strong peak 
(green) on chromosome 3L. The blue and red horizontal lines indicate the nominating (P 
< 10-5) and the genome-wide threshold (Bonferroni corrected P < 0.05), respectively. 
(D) UCSC browser view of the sfl locus containing the association peak. The intron 
containing the peak also contains a nested gene CG32396.	  	  
A B
C
D
Window Position
Scale
chr3L:
D. melanogaster Apr. 2006 (BDGP R5/dm3)
20 kb
6,500,000 6,510,000 6,520,000 6,530,000 6,540,000
GWAS -log10 p-values
FlyBase Protein-Coding Genes
from Graveley 2011 Science
CG10144
sfl
CG32396
sfl.b,sfl.c,sfl-RB,sfl-RA
sfl.a
sfl-RA
sfl.b,sfl.a,sfl-RA
sfl.b,sfl.c,sfl.a,sfl-RB,sfl-RA
inclusion_exon
sfl_TCONS_00148235,sfl.b,sfl.c,sfl.a,sfl-RB,sfl-RA
sfl_TCONS_00148235,sfl.b,sfl.c,sfl.a,sfl-RB,sfl-RA
sfl.b,sfl.c,sfl_TCONS_00148235,sfl-RB,sfl-RA
sfl-RA
sfl-RB,sfl-RA
sfl.a
sfl.b,sfl.c
-log10 p-values
7.62252 _
0 _
7.62
12	  	  
the threshold in each of the 2,000 trials had a mean of 21 and a median of 19, with the 
observed number 29 at the 85th percentile. Both methods suggest a modest enrichment 
of true positives under the 10-5 threshold. 	  
sulfateless (sfl) modifies eye area phenotype 
The peak on chromosome 3L is confined to the third intron of the gene, sfl (Figure 2D). 
This intron also contains a nested gene (CG32396) lying close to the association peak. 
CG32396 is predicted to encode a protein with a probable tubulin beta-chain. To 
determine which of the two genes, or possibly both, is responsible for the association 
signal, we examined the expression pattern of each gene and also used RNAi to knock 
down gene expression. sfl is expressed in the eye-antennal imaginal disc and eye and 
brain in adults (Figure S5, S6). CG32396 has a testis-specific expression pattern in 
adults, with very low expression in the adult eye (Figure S5) and no detectable 
expression in eye imaginal discs by RT-PCR (Figure S6, S7). 	  
 RNAi knockdown of either sfl or CG32396 in the eye imaginal disc had no 
measurable effect on eye area. In contrast, RNAi against sfl, but not CG32396, 
significantly decreased mean eye area in the presence of hINSC96Y but not hINSWT  
(Figure 3). These results identify sfl, and not CG32396, as the causal gene underlying 
the association peak. 
 To test if sfl also modifies the hINSC96Y-induced phenotype in other tissues, we 
carried out RNAi knockdown of sfl in the developing wing (using a dpp-Gal4 driver) and 
notum (using an ap-Gal4 driver). In both experiments we observed more severe 
phenotypes than that caused by hINSC96Y alone (Figure S8, S9). However, the 
interpretation is made complicated by the fact that sfl knockdown alone causes mutant 
phenotypes in these tissues, consistent with previous knowledge (Lin, 2004). At present 
we cannot distinguish the alternative hypotheses of additive vs. epistatic interactions 
between sfl and hINSC96Y.	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Figure 3  RNAi knockdown confirms sfl and excludes CG32396 as the causal gene. 
The effect of knocking down either CG32396 or sfl was tested in the absence ({UAS-
RNAi} x {GMR-Gal4}) or presence ({UAS-RNAi} x {GMR-Gal4, UAS-hINSC96Y}) of 
hINSC96Y. Compared to the control crosses (first and third columns in both sexes), 
significant difference in mean eye area was observed only with RNAi against sfl and 
only in the presence of hINSC96Y (n=15, asterisks above a box plot indicate significant 
differences at 0.05 level determined by a student's t-test, with Bonferroni correction for 
multiple testing). In box plots, the median (black dot), interquartile (box) and 1.5 times 
the interquartile range (whiskers) are indicated; data points outside the range are 
represented by circles.	  	  
Heparan Sulfate Biosynthetic pathway modifies the hINSC96Y-induced eye 
degeneration 
Sulfateless encodes a bi-functional enzyme in the HSPG biosynthesis pathway. An 
important component of the cell surface and extracellular matrix (Kirkpatrick & Selleck, 
2007), Heparan sulfate-modified proteins, or proteoglycans (HSPG) are known to 
regulate signaling during development, influencing the levels and activity of growth 
factors and morphogens at cell surfaces and in the extracellular matrix (Fujise et al., 
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2003; Giráldez et al., 2002; Häcker et al., 1997; Kirkpatrick et al., 2004; Nakato et al., 
1995). The involvement of HSPGs in the cellular responses to misfolded proteins 
(proteostasis) has not been previously described. 	  
 To further examine the hINSC96Y-dependent interaction of sfl, we examined RNAi 
knockdowns and mutants for two additional genes in the HS biosynthetic pathway: ttv 
and botv, producing the glycosaminoglycan polymer that is modified by sfl (Lin, 2004). 
Neither of the genes contains significant SNPs in our GWAS (lowest adjusted P > 0.5 in 
both loci, adjusted for multple-testing using either Bonferroni's method or Benjamini & 
Hochberg method). RNAi knockdown of both genes shows a hINSC96Y-dependent effect 
on eye area in the same direction as sfl RNAi (Figure 4). In addition, a mutant allele of 
botv also showed a significant dominant enhancement of the eye degeneration 
phenotype. These results implicate HSPGs in modifying the cellular response to 
misfolded proteins. Neither of the genes were identified in the GWAS, however, 
indicating either a lack of disease-affecting variation in these genes in this natural 
population or the lack of statistical power to detect them.	  	  
Intronic enhancer and sfl expression 
We re-sequenced a 3 kb region containing the GWAS peak in sfl (and the nested gene 
CG32396) in 19 of the 154 DGRP lines and the transgenic hINSC96Y stock to identify all 
the variants in this region. We found that the SNP achieving the lowest p-value genome-
wide was an 18 bp/4 bp length polymorphism (relative to the D. simulans orthologous 
sequence) (Figure 5A). We also found three other insertion/deletion (INDEL) 
polymorphisms in this region, with sizes ranging from 4 – 30 bp and the minor alleles 
(deletion in all three cases) being present only once or twice in the sample. In contrast, 
the 18/4 bp polymorphism is present at 50% frequency in the DGRP sample. In light of 
the discovery of mislabeled and undiscovered INDELs, we will use the term "Single 
Feature Polymorphism" (SFP) when referring to variants in the sfl locus. 
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Figure 4  RNAi and mutant analysis for HSPG biosynthesis pathway genes. The 
experimental design is the same as in Figure 3. Left panel shows the effect of RNAi or 
mutant alleles in the absence of hINSC96Y expression; right panel shows the effect when 
hINSC96Y is expressed in the eye imaginal disc. Mutants were tested in heterozygous 
states for a dominant interaction with hINSC96Y. Fifteen male flies are measured for each 
group. The statistical significance of differences from the control cross (gray, w1118) 
was determined by a two-sided student's t test. Those that are significant at 0.05 level 
after Bonferroni correction are marked with a red arrowhead.	  	  	  
 A plot of haplotype structure surrounding the association peak (Haploview v4.2) 
shows an LD block of 400 bp (block 66 in Figure 5A, chr3L:6523119-6523518). There 
are two major haplotypes, which we name after the 18/4 bp length polymorphism, each 
represented by two equal-sized groups among the 154 DGRP lines (Figure 5B). 
Because all coding variants in sfl lie outside of this 400 bp LD block, we hypothesized 
that one or more of these intronic SFPs are the causal variant(s) and modify the 
hINSC96Y-induced eye phenotype by altering sfl expression.  
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Figure 5  Sanger re-sequencing of a 3kb region under the peak and the linkage 
patterns in the region. (A) Alignment of 19 DGRP sequences ordered by their eye 
degeneration phenotype (mean, most severe on the bottom). The hINSC96Y transgenic 
line (asterisk) was also sequenced. Red ticks and white spaces indicate SNPs and 
deletions relative to the reference sequence. No insertions relative to the reference 
were found. The purple track shows the -log10 of GWAS p-values. The bottom track 
shows the linkage blocks as determined by Haploview (4.02) using the solid spine 
method with default settings (D' > 0.8). (B) Detailed haplotype block structures. Each 
numbered column represents a polymorphic site, with the alleles colored as blue or red; 
each row represents a haplotype with frequency > 0.01. An arrowhead marks the 
18/4bp indel polymorphism (see text; 18bp: blue; 4bp: red). Finally, the number between 
any two blocks represents the multi-allelic D', which quantifies the associations between 
adjacent blocks.	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 To test this hypothesis, we crossed randomly selected pairs of 4 bp and 18 bp lines 
to obtain F1 individuals heterozygous for the two alleles. We then used pyro-sequencing 
to estimate the relative expression of the two alleles in eye imaginal discs. This method 
allowed us to measure the ratio of expression of sfl associated with each allele in the 
same animal, thereby controlling for both the trans-environment as well as experimental 
noise, resulting in highly reproducible results (Figure S10). To account for the 
heterogeneity due to variation in other parts of sfl or elsewhere in the genome, we 
randomly chose six and eight lines carrying the 18 bp or 4 bp allele, respectively, and 
used them to form 15 crosses (Figure S1A). Based on RNAi knock-down of sfl, which 
enhanced the hINSC96Y phenotype, we expected the 4bp allele (associated with more 
severe phenotypes in the GWAS) to produce less transcript than the 18bp allele. 
 Allele-specific expression of sfl differed in both magnitude and direction among the 
15 crosses (Figure 6). Seven crosses supported the hypothesis by exhibiting 
significantly greater expression from the 18 bp allele, with an 18/4 bp ratio ranging from 
1.03 - 2.8 (median = 1.15). Two crosses, however, showed slightly greater expression 
from the 4 bp allele (18 bp/4 bp ratios of 0.94 and 0.96). The remaining six crosses 
showed no significant differences in expression of the two alleles. The trend towards 
more expression of the transcript linked to the 18bp allele supports the hypothesis that 
the 18/4 bp intronic polymorphism (and/or other SFPs in the 400bp LD block) modulates 
sfl expression. However, heterogeneity in allele-specific expression between crosses 
indicates the presence of additional cis-acting expression variants. 	  	  
Search for Additional Association by Conditional Analysis  
In light of the above finding, which suggests additional variants influencing sfl 
expression, we carried out a conditional analysis to identify variants that act 
independently of the 18bp/4bp SFP. To do so, we tested variants other than the 18/4bp 
SFP, either within the sfl locus or genome-wide, by treating the 18/4bp SFP as a 
covariate in a linear regression model. After accounting for multiple testing, we 
observed no significant signals in either case (Figure S11). The lack of significance 
genome-wide may be attributable to the lack of power after correcting for multiple  
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Figure 6  Pyro-sequencing measure of sfl allele-specific transcript ratio in 18bp/4bp 
heterozygotes. (A) A diagram of the pyro-sequencing approach. Colored lines represent 
transcripts (mRNA) associated with either the 18bp or the 4bp allele, expressed at 
different levels. Common primers were used to amplify both transcripts of the gene of 
interest from the cDNA library made from eye imaginal disc tissues. Pyro-sequencing 
was carried out on the amplified products. (B) A pyrogram of a heterozygote with the 
polymorphic site (G/C) that is diagnostic for the 18bp/4bp indel highlighted. The ratio of 
the two peaks (light intensity, y-axis) are used to calculate the relative ratio of the two 
alleles. (E: enzyme, S: substrate, A/C/G/T: nucleotides). (C) Log2 transformed ratio of 
18bp/4bp allele expression in 15 crosses between randomly paired 18bp and 4bp lines. 
Estimates of the ratio and 95% confidence intervals are plotted. The dotted line 
corresponds to equal expression from the two alternative alleles. 
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testing. The analysis restricted to the 40kb sfl locus reduces the burden of multiple 
testing by several orders of magnitude, but also fails to identify a significant association. 
Considering the large range of allele-specific expression differences between the 18bp 
and 4bp alleles observed in the 15 crosses, the additional cis-acting expression variants 
must either be low frequency alleles or have epistatic properties, two situations this 
analysis would be underpowered to detect.  
 
DISCUSSION 
HSPG function and misfolded protein response 
Our study identified the heparan sulfate biosynthesis pathway (sfl, ttv and botv) as a 
modifier of eye degeneration induced by expression of a misfolded human proinsulin 
protein. Although we do not yet know whether this response is to a specific misfolded 
protein (hINSC96Y) or whether it applies to a broader class of misfolded proteins, our 
discovery now implicates the HSPGs in the regulation of cellular proteostasis. 
 We propose that genetic variation in HSPG biosynthesis influences the response to 
misfolded protein through its biological activity in vesicular trafficking of misfolded 
protein. HSPG are abundant components of cell surfaces and extracellular matrices, 
and are best understood for their roles in cell signaling and in functioning as co-
receptors, both of which are integral to normal development (Häcker et al., 2005; 
Kirkpatrick & Selleck, 2007). HSPG are also involved in endocytocis (Ren et al., 2009; 
Stanford et al., 2009) and vesicular trafficking (Nybakken & Perrimon, 2002; Sarrazin et 
al., 2011), roles that link them to cellular response to misfolded proteins (Higashio & 
Kohno, 2002; Kim et al., 2009; Kimmig et al., 2012).  
 It is feasible that HSPGs influence membrane trafficking indirectly, perhaps by 
regulating signaling events that impinge on trafficking processes. The generation of 
phosphatidylinositol (3,4,5) triphosphate [PtdIns(3,4,5)P3] by type I phosphoinositide 
(PI) 3-kinases is affected by a number of growth factors and cytokines, many of which 
are influenced by HSPGs as accessory molecules. PtdIns(3,4,5)P3 affects a number of 
trafficking events, including endocytosis and autophagy  (Downes et al., 2005).  
 In a yeast study of the mutant protein folding assistant, protein disulfide isomerase 
(Pdi1a'), the authors found that more than half of the 130 genes identified as synthetic-
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lethal were related to vesicle trafficking, while only 10 belonged to the canonical 
unfolded protein response (UPR) pathway (Kim et al., 2009). In another study, Kimmig 
et al found an enrichment of vesicle-trafficking related genes among those that changed 
expression significantly after induction of ER-stress (Kimmig et al., 2009). Both studies 
indicate that a global regulation of vesicle trafficking is important to a cell’s response to 
unfolded or misfolded protein. Activation of UPR has also been shown to affect ER-to-
Golgi transport via stimulation of COPII vesicle formation from the ER (Higashio & 
Kohno, 2002). We therefore propose that either natural variation or genetic perturbation 
of HS biosynthesis influences the global regulation of vesicle trafficking, which in turn 
affects cells' ability to process an excess of unfolded or misfolded protein. Prolonged 
ER-stress may then lead to apoptosis. 	  
Genetic Architecture of the hINSC96Y-induced eye degeneration phenotypes 
Phenotypic heterogeneity that is dependent on the genetic background is a common 
phenomenon, and in humans, imposes a significant challenge in both diagnosis and 
treatment. Our fly model provides a tractable system for studying the genetic and 
molecular basis for such phenotypic heterogeneity, but with limitations imposed by the 
sample size of the study. sfl is the only significant QTL identified under a highly stringent 
threshold. A less stringent cutoff of P < 10-5 identifies 29 SNPs in 16 loci; permutation 
test, however, finds this number at 85% percentile among 2,000 randomly shuffled 
datasets, suggesting that the false discovery rate may be high. A simple calculation for 
a t-test based statistic at P = 0.05 level with Bonferroni's correction for multiple testing 
indicates that we will have 66% power to identify a variant at 50% population frequency, 
with an effect-size of 1 (measured as the shift in phenotypic mean in units of standard 
deviation of the trait, see Table S4). This example was chosen to match the estimates 
for the 18bp/4bp indel polymorphism in the sfl intron in the sample of 154 crosses. Any 
variant with a smaller effect-size and/or lower frequency than the 18bp/4bp 
polymorphism would have been missed in this study with a high probability.  
 The genetic architecture for the hINSC96Y-induced eye phenotype must involve many 
loci in addition to sfl, as is evident from the continuous distribution of the between-line 
phenotypes in crosses between the DGRP lines and GMR>>hINSC96Y tester strain 
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(Figure 1). We applied a mixed-linear model to the mean phenotype for the 154 crosses 
to estimate the total contribution of common variants to the phenotypic variance (Yang 
et al., 2010). This method does not identify individual SNP, and thus does not suffer 
from the multiple-testing burden as in GWAS. Applying this method  (Yang et al., 2011), 
52% (standard error = 28%) of the variance between crosses (i.e. genotypes) can be 
attributed to common, autosomal variants with minor allele frequencies greater than 5%. 
Although this estimate has a large standard error, resulting from the limited number of 
lines, it nevertheless indicates contributions by many additive factors beyond sfl, most of 
which likely have small effect sizes or low population frequencies, making them not 
detectable in our study. 
 An additional layer of genetic complexity was revealed when we tested the effects of 
the intronic SFPs on sfl expression. Among the 15 crosses where we randomly paired 
an 18bp allele line with a 4bp allele line from DGRP, seven showed greater expression 
from the 18bp-linked allele than the 4bp-linked allele; six showed no significant 
differences while two showed small, yet significant differences in the opposite direction. 
While the general trend is as expected (Figure 6), the phenotypic heterogeneity 
suggested that additional variation is influencing sfl expression. The variants most likely 
lie within the sfl locus because the experiment specifically measures allele-specific 
expression in heterozygotes, which means any trans-variant will have to act in an allele-
specific manner. A conditional analysis using the 18bp/4bp polymorphism as a covariate 
failed, however, to identify secondary SFPs in the sfl locus, most likely due to lack of 
power.  
 	  
Relationship to common, complex diseases 
While our fly model is of a monogenic form of diabetes, it exhibits a complex genetic 
architecture when placed on a diverse set of genetic backgrounds. Here we would like 
to argue that fly models of monogenetic disease are suitable subjects for the genetic 
dissection of common disorders in human. 
 One role of the Mendelian mutation is to sensitize the fly to allow phenotypic effects 
of background genetic modifiers to become visible. Although common disorders are 
normally considered as lacking a major mutation, a careful consideration suggests that 
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this view is inaccurate. What common disorders lack are large-effect mutations shared 
by a substantial proportion of the affected individuals. For many diseases, perturbation 
may be required to boost the expressivity of additive genetic variation that would 
otherwise be cryptic, i.e., below a disease-causing threshold.  Such a perturbation could 
be genetic, such as driver mutations in cancer, but could also be environmental, such 
as diet and life-style changes in the case of cardiovascular disease and type 2 diabetes. 
Consistent with this view, it has been proposed that recent genome evolution and rapid 
environmental as well as cultural changes in human history have decanalizing effects 
on physiology, which release cryptic genetic variation and underlie the rising incidence 
of common human disorders (Gibson, 2009).  
 A genetic screen for naturally occurring modifiers in a sensitized background, such 
as the one we employed here, should apply equally well in the study of Mendelian or 
complex disease. Were this not the case, two different classes of genetic modifiers 
would have to be posited. An intriguing question, which we found little empirical 
evidence for or against, could be addressed in the fly by constructing a series of 
sensitized backgrounds utilizing different disease-causing mutant hINS alleles of 
varying effect on disease (e.g., neonatal diabetes vs. maturity-onset diabetes of the 
young Støy et al., 2007), and comparing the composition of naturally occurring modifiers. 
 
Advantages of a fly model of complex disease  
A primary mutation can manifest itself in different ways and with tissue-specific effects 
(Mefford et al., 2008), possibly a consequence of its interdependence with the 
individual’s genetic background. The binary Gal4-UAS system enables the creation of a 
series of models using the same disease mechanism, but directed to different tissues 
with high tissue-specificity. The ability to construct and study multiple related models in 
parallel can provide insight into the basis of disease heterogeneity. In the accompanying 
paper we show, for example, that the developing eye and notum have different sets of 
genetic background modifiers of mutant hINS-dependent disease (Park et al., 2013). 
Sex-specific difference in disease risk and severity are also readily modeled in the fly. In 
both the fly and mouse model of hINSC96Y-induced disease, males consistently show 
more severe disease phenotypes (Wang et al., 1999, Park et al., 2013).  
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 Drosophila models of human disease provide a useful alternative to the study of a 
complex disease in patient populations. First, many models of human disease have 
been established in the fly, most notably neurodegeneration and cancer (Bilen & Bonini, 
2005; Gonzalez, 2013). We predict that natural variation will influence the severity of 
disease phenotypes in all of them. Second, many models of disease can be created by 
over-expression of a mutant allele, which makes them suitable for F1 screens between 
a tester stock and inbred population collections, such as we employed here. Our study 
shows that an impressive amount of genetic variation for disease severity is dominant or 
semi-dominant; this outcrossing design also avoids unwanted effects of inbreeding on 
traits and better mimics the natural heterozygosity of low frequency variants. Third, this 
experimental design facilitates repeated measurement of a disease phenotype, thereby 
increasing the power to detect a causal association (Mackay et al., 2009). Fourth, LD is 
low in D. melanogaster and SNP is 20-40X more abundant than in human. Finally, both 
forward and reverse genetics can be applied to investigate the biology and pathway 
genetics of candidate variants. For all these reasons we believe fly models will prove 
useful in understanding the genetic architecture of complex human disease. 
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SUPPLEMENTARY TABLES 
Table S1 DRRP lines used in this study 
Line Stock 
RAL-101 28138 
RAL-105 28139 
RAL-109 28140 
RAL-129 28141 
RAL-136 28142 
RAL-138 28143 
RAL-142 28144 
RAL-149 28145 
RAL-153 28146 
RAL-158 28147 
RAL-161 28148 
RAL-176 28149 
RAL-177 28150 
RAL-195 28153 
RAL-208 25174 
RAL-21 28122 
RAL-217 28154 
RAL-227 28156 
RAL-228 28157 
RAL-229 29653 
RAL-233 28159 
RAL-235 28275 
RAL-237 28160 
RAL-239 28161 
RAL-256 28162 
RAL-26 28123 
RAL-28 28124 
RAL-280 28164 
RAL-287 28165 
RAL-301 25175 
RAL-303 25176 
RAL-304 25177 
RAL-307 25179 
RAL-309 28166 
RAL-310 28276 
RAL-313 25180 
RAL-315 25181 
RAL-318 28168 
RAL-320 29654 
RAL-321 29655 
RAL-324 25182 
RAL-325 28170 
RAL-332 28171 
RAL-335 25183 
RAL-338 28173 
RAL-350 28176 
RAL-352 28177 
RAL-356 28178 
RAL-357 25184 
RAL-358 25185 
RAL-359 28179 
RAL-360 25186 
RAL-362 25187 
RAL-365 25445 
RAL-367 28181 
RAL-371 28183 
RAL-373 28184 
RAL-374 28185 
RAL-375 25188 
RAL-377 28186 
RAL-379 25189 
RAL-38 28125 
RAL-380 25190 
RAL-381 28188 
RAL-383 28190 
RAL-386 28192 
RAL-391 25191 
RAL-399 25192 
RAL-40 29651 
RAL-405 29656 
RAL-406 29657 
RAL-409 28278 
RAL-41 28126 
RAL-42 28127 
RAL-426 28196 
RAL-427 25193 
RAL-437 25194 
RAL-439 29658 
RAL-440 28197 
RAL-441 28198 
RAL-443 28199 
RAL-45 28128 
RAL-461 28200 
RAL-486 25195 
RAL-491 28202 
RAL-492 28203 
RAL-502 28204 
RAL-508 28205 
RAL-509 28206 
RAL-513 29659 
RAL-517 25197 
RAL-531 28207 
RAL-535 28208 
RAL-555 25198 
RAL-563 28211 
RAL-57 29652 
RAL-589 28213 
RAL-59 28129 
RAL-595 28215 
RAL-639 25199 
RAL-642 28216 
RAL-646 28217 
RAL-69 28130 
RAL-703 28218 
RAL-705 25744 
RAL-707 25200 
RAL-712 25201 
RAL-714 25745 
RAL-716 28219 
RAL-721 28220 
RAL-73 28131 
RAL-730 25202 
RAL-732 25203 
RAL-737 28222 
RAL-738 28223 
RAL-75 28132 
RAL-761 28227 
RAL-765 25204 
RAL-774 25205 
RAL-776 28229 
RAL-783 28230 
RAL-786 25206 
RAL-787 28231 
RAL-790 28232 
RAL-796 28233 
RAL-799 25207 
RAL-801 28234 
RAL-802 28235 
RAL-805 28237 
RAL-808 28238 
RAL-810 28239 
RAL-812 28240 
RAL-818 28241 
RAL-820 25208 
RAL-822 28244 
RAL-83 28134 
RAL-837 28246 
RAL-85 28274 
RAL-852 25209 
RAL-855 28251 
RAL-857 28252 
RAL-859 25210 
RAL-861 28253 
RAL-879 28254 
RAL-88 28135 
RAL-882 28255 
RAL-884 28256 
RAL-887 28279 
RAL-890 28257 
RAL-894 28259 
RAL-897 28260 
RAL-908 28263 
RAL-91 28136 
RAL-911 28264 
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Table S2 Sequence primers used in this study 
Name Sequence (5'->3') 
qRT-PCR 
sfl_F1 TCGATACGGGCGTGTTTAATGGAC 
sfl_R1 TTGATAATGGGTGCGGGATGCG 
CG32396_F1 AGCGGAGATTGGGTCGAAATGAG 
CG32396_R1 CATGTGAAATCACGTGCCAGAAAG 
kl-3F1 ATGGCAAACGTAGACCCACCTC 
kl-3R1 GTACCGGCGGACGATTCTTTAG 
Pp1-Y2F1 TTTGTTGTCACGGCGGTCTCAG 
Pp1-Y2R1 ACGTCACATGGTCGGGCTAATTG 
RP49-F1 CGGATCGATATGCTAAGCTGT 
RP49-R1 GCGCTTGTTCGATCCGTA 
Pyro-seq 
1336F1 CGGGCGGCAATCAACATAA 
1336R1 CGGTCACGGAGCTACCAAATT 
1336S1 CTCATTAAGCAGCCG 
2789F1 GACTGCGACCAGATGATGTGAG 
2789R1 CTTCCCTCGTGCCATGATGATA 
2789S1 TTCCCGAGAATCCCA 
2854F1 CGGGAAAATACTATCATCATGGC 
2854R1 GTGCGAAAACCAGTTGAACTC 
2854S1 TCCTGAACGTTCTGC 
1885F1 TAATGGACTTATTCAACGCGACAC 
1885R1 TGTGTTTGCCACCAGAGTTG 
1885S1 CGGCAGTTGATAATGG 
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Table S3 Annotation of SNPs below 10-5 p-value threshold 
Chr Position Gene Symbol Site Class MAF P 
2L 6018257 H2.0 intronic 0.15 4.11E-06 
2L 7639113 CG13792 intergenic 0.42 3.28E-06 
2L 7639113 CG6739 intergenic 0.42 3.28E-06 
2L 16378839 CG5888 intergenic 0.11 5.89E-07 
2L 16378839 jhamt intergenic 0.11 5.89E-07 
2R 6830823 Spn47C intergenic 0.05 8.91E-06 
2R 6830823 luna intergenic 0.05 8.91E-06 
2R 8514952 CG17760 intronic 0.08 7.11E-06 
2R 16411003 CG13422 intergenic 0.17 9.29E-06 
2R 16411003 CG13426 intergenic 0.17 9.29E-06 
3L 6523119 sfl intronic 0.47 2.38E-08 
3L 6523164 sfl intronic 0.43 1.98E-06 
3L 6523166 sfl intronic 0.43 1.82E-06 
3L 6523167 sfl intronic 0.42 1.59E-06 
3L 6523212 sfl intronic 0.49 3.56E-07 
3L 6523285 sfl intronic 0.48 3.08E-07 
3L 6523298 sfl intronic 0.49 2.67E-07 
3L 6523484 sfl intronic 0.42 5.18E-08 
3L 8372543 ImpE1 intronic 0.21 7.87E-06 
3R 9282003 CG14372 intronic 0.05 5.12E-06 
3R 9282011 CG14372 intronic 0.05 5.12E-06 
3R 13265256 CG5873 intronic 0.03 8.95E-06 
3R 13265256 CG14331 intronic 0.03 8.95E-06 
3R 13265265 CG5873 intronic 0.03 9.52E-06 
3R 13265265 CG14331 intronic 0.03 9.52E-06 
3R 13265268 CG5873 intronic 0.03 9.52E-06 
3R 13265268 CG14331 intronic 0.03 9.52E-06 
3R 16891400 AnnIX intronic 0.45 7.66E-06 
3R 16891456 AnnIX intronic 0.45 7.97E-06 
3R 17323042 C15 intergenic 0.43 9.08E-06 
3R 17323042 CG7922 intergenic 0.43 9.08E-06 
3R 17323100 C15 intergenic 0.32 2.11E-06 
3R 17323100 CG7922 intergenic 0.32 2.11E-06 
3R 19762489 Gdh intronic 0.39 8.26E-06 
3R 19968993 kal-1 intronic 0.35 8.25E-06 
3R 23486244 CG18437 intergenic 0.49 3.24E-06 
3R 23486244 Mlc1 intergenic 0.49 3.24E-06 
3R 24918157 CG11873 intronic 0.49 3.48E-06 
3R 24920070 CG11873 intronic 0.41 8.00E-06 
X 18241719 CG6123 intronic 0.03 5.88E-06 
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Table S4 Power calculation for GWAS with 154 lines 
Effect Size* 
MAF 0.75 1 1.25 1.5 2 
0.01 0.00 0.00 0.00 0.00 0.00 
0.05 0.00 0.00 0.01 0.03 0.26 
0.1 0.00 0.02 0.12 0.39 0.94 
0.2 0.02 0.19 0.63 0.94 1.00 
0.3 0.06 0.45 0.90 1.00 1.00 
0.4 0.11 0.60 0.96 1.00 1.00 
0.5 0.13 0.66 0.97 1.00 1.00 
* Effect size is measured as the shift in the phenotype mean in units of s.d. for 
the trait 
The calculation is done using the t-distribution. The R-code is attached below: 
 
myPower.t <- function(effect.size=1,alpha=0.05,m,n){  
  ## Power for GWAS t test    
  ## calculate power for a t test comparing two populations with equal variance but unequal 
sample sizes 
  ## m, n: sample size of each allele class, not to be confused with m above 
  df = m+n-2      
  A = 1/sqrt(1/m+1/n) ## factor for calculating t statistics 
  T = qt(1-alpha/2,m+n-2)    
  T1 <- T-effect.size*A    
  beta <- pt(T1,m+n-2)     
  return(1-beta)     
}      
## plot power of GWAS t test ##    
alpha1=.05/1.37e6     
power <- NULL     
effect.size <- c(0.75,1,1.25,1.5,2)   
freq <- c(0.01,0.05,0.1,0.2,0.3,0.4,0.5)   
N = 154 # size of GWAS mapping population   
for(p in freq){     
  m = as.integer(N*p)     
  n = N-m      
  power <- rbind(power, sapply(effect.size,function(x) myPower.t(x,alpha1,m,n))) 
}      
dimnames(power) <- list("freq"=freq,"effect.size"=effect.size) 
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SUPPLEMENTARY FIGURES 
 
 
 
 
 
Figure S1  Pyro-sequencing cross and assay design. (A) Cross design for pyro-
sequencing. Six 18bp and eight 4bp lines were randomly chosen from the 154 
DGRP lines used in GWAS. The Bloomington center stock number is listed. In 
each cell, the order of the letter/number indicate the direction of the cross. For 
example, A1 indicates that males of #28240 was crossed to virgin females of 
#28190. (B) pyro-sequencing assays. Four SNPs were selected within the 
transcribed regions so as to distinguish alleles associated with the 18/4 bp indel 
polymorphism. 
 
 18bp 28190 28141 28178 28144 28135 28171 
4bp  A B C D E F 
28240 1 A1 1B     
28231 2  B2 2C    
28138 3   C3   3F 
25204 4    D4 4E  
28211 5 5A    E5 5F 
28227 6    6D  F6 
28139 7      F7 
28122 8   C8    
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Figure S2  Correlations of eye area between F1 males and females within the 
same cross. Mean ± 1 s.d. are plotted for a subset of 38 lines. The least square 
linear fit is indicated. 
 
34	  	  
Figure S3  Population structure assessed through principal component analysis 
(PCA) using 900K autosomal SNPs after LD pruning. (A) 154 DGRP inbred lines 
projected onto the plane spanned by the first two principal components (PC1, 
PC2). The points are colored according to the phenotype severity in the hINSC96Y 
crosses (red: severe, or first 25%; blue: intermediate, 25%-75%; green: mild, 
75%-100%, percentiles in eye area distribution from small to large). (B) projection 
onto PC1 grouped by their phenotype severity showed no correlation between 
the two. 
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Figure S4  All SNPs with p-values below 10-5 from GWAS. (A) Composite plot: 
from top to bottom are minor allele frequencies, effect sizes, -log10 (p-values) 
and the bottom triangle represent the linkage map between these SNPs grouped 
by chromosomes. (B) Distribution of the number of SNPs with a p-value < 10-5 in 
2000 permutations, where the line identities in each trial was shuffled randomly 
and the same association analysis was applied. Red triangle indicate the 
observed number of SNPs in the real data, which is at 85th percentile among the 
2000 permutations. 
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Figure S5 FlyAtlas expression report for CG32396 and sfl. (A) CG32396 (B) sfl. 
Figure obtained through FlyBase. 
 
A
B
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Figure S6 qRT-PCR quantification of mRNA levels for CG32396 and sfl in eye 
imaginal disc samples.  Two inbred lines from DGRP were randomly chosen and 
eye imaginal disc samples were prepared from either 6 male or 6 female larvae, 
resulting in 4 biological samples. qRT-PCR were performed for each sample and 
three genes (RP49 -- red curve, sfl -- yellow, and CG32396 -- green). Shown is 
the amplification plot: x-axis -- cycle number; y-axis -- base-line corrected relative 
fluorescence intensity proportional to the amount of amplicons. Both RP49 and 
sfl were detected starting in the 18-20th cycle, while amplification didn't happen 
for CG32396 until after 32 cycle. In addition, multiple melting points were 
detected for CG32396 assays, but not in the other two genes. 
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Figure S7 Relative quantity of mRNA quantified by qRT-PCR in male and female 
larvae.  In each category, the first three bars represent three independent female 
larvae sample (whole larva), each assayed with three technical replicates. The 
height of the bar represent the mean and the full range of RQ values were 
indicated by the error bars. The next three bars correspond to three independent 
male larvae assayed for the same gene. kl-3 and Pp1-Y2 are both located on the 
Y-chromosome and are known to have a testis-specific expression level. The RQ 
values were measured using RP49 gene as the internal control, and the first 
female larva sample (F-1) as the reference, whose RQ is set to one. 
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Figure S8  Depletion of sfl by RNAi in the developing wing expressing hINSC96Y 
driven by dpp-Gal4. For both females and males, dpp >> hINSC96Y or Dpp >> sfl 
RNAi expression alone reduces wing area between the L2 and L4 longitudinal 
veins relative to the posterior-most sector of the wing (bordered by L5). This 
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reduction is more severe in the sfl knockdown genotype than in the hINAC96Y-
expressing genotype. Co-expression of sfl RNAi and hINS C96Y by dpp-Gal4 
results in the obliteration of the L3 vein and further relative reduction of the L2-L4 
area. 
(A): Wild type wing showing the measured regions of wing used to quantify the 
effects of both sfl RNAi and hINSC96Y expression in dpp-Gal4 domain (L3-L4 
intervein sector).  Quantification of the (B) female or (E) male wing phenotypes 
generated by transgenes dpp-Gal4; dpp-Gal4 >UAS-hINSC96Y; (C, G) dpp-Gal4 
>> UAS-sfl RNAi; and (D, H) dpp-Gal4 >>UAS-sfl RNAi; UAS-hINSC96Y. The 
values represent the ratio of the third posterior cell (in pink color) divided by the 
L2-L4 intervein sector (in green color) wing area. ***, P < 0.001; Mann-Whitney U 
test.  
Females: dpp-Gal4 (n= 15; Mean= 0.62), dpp-Gal4 >UAS-hINSC96Y (n= 15; 
Mean=0.65), dpp-Gal4 >> UAS-sfl RNAi (n= 23; Mean=1.3) and dpp-Gal4 
>>UAS-sfl RNAi; UAS-hINSC96Y (n= 22; Mean=1.76). 
Males: dpp-Gal4 (n= 15; Mean=0.59), dpp-Gal4 >UAS-hINSC96Y (n= 15; 
Mean=0.64), dpp-Gal4 >> UAS-sfl RNAi (n=23; Mean=1.2 ) and dpp-Gal4 
>>UAS-sfl RNAi; UAS-hINSC96Y (n= 29; Mean=1.68). 
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Figure S9  Depletion of sfl by RNAi in the developing notum expressing hINSC96Y 
driven by ap-Gal4. For both females and males, ap > hINSC96Y or ap > sfl RNAi 
expression alone reduces notum area and causes loss of dorsal macrochaetae. 
Co-expression of sfl RNAi and hINSC96Y by ap-Gal4 results in greater destruction 
of the notum and macrochaetae in both sexes. However, in the male the notum 
and additional dorsal structures are obliterated and this phenotype is lethal. 
ap-Gal4 > hINSC96Y (A) female and (D) male; 
ap-Gal4 >  sfl RNAi (B) female and (E) male; 
ap-Gal4>> hINSC96Y, sfl RNAi (C) female (F) male 
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Figure S10  log2 transformed ratios between transcript levels associated with 
18bp/4bp alleles. The allele-specific expression ratios were measured in F1 
hybrid individuals by pyro-sequencing, with three (or four) biological replicates 
and four (or three) pyro-technical replicates, to obtain a total of 12 measurements. 
In each of the 15 crosses, the technical replicates were plotted in a single column, 
with different columns representing the biological replicates. In the titles of each 
panel, the last three digits in the stock number were shown for lines used in the 
cross. 
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Figure S11  Conditional regression analysis to detect additional SNPs 
associated with the phenotype of interest. (A) within the sfl locus;  (B) all 
chromosomes. The intronic 18/4bp polymorphism in sfl is included in the linear 
model as a covariate. The two dotted lines in (A) correspond to a single test 0.05 
level (red) and the multiple testing corrected 0.05 level using Bonferroni's method 
(blue). The red line in (B) represents the Bonferroni corrected 0.05 level. 
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